Streptomycin sulfate dry powder inhalers for the new tuberculosis treatment schedule

Andrade, 2013, Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases, Adv. Drug Deliv. Rev., 65, 1816, 10.1016/j.addr.2013.07.020 Gupta, 2012, Colloidal carriers: a rising tool for therapy of tuberculosis, Crit. Rev. Ther. Drug Carrier Syst., 29, 10.1615/CritRevTherDrugCarrierSyst.v29.i4.20 Krause KM, Serio AW, Kane TR, Connolly LE. Aminoglycosides: an overview. Cold Spring Harbor perspectives in medicine.6(6):a027029. Quon, 2014, Inhaled antibiotics for lower airway infections, Annals of the American Thoracic Society, 11, 425, 10.1513/AnnalsATS.201311-395FR Maurin, 2001, Use of aminoglycosides in treatment of infections due to intracellular bacteria, Antimicrob. Agents Chemother., 45, 2977, 10.1128/AAC.45.11.2977-2986.2001 Al-Nemrawi, 2018, Low molecular weight chitosan-coated PLGA nanoparticles for pulmonary delivery of tobramycin for cystic fibrosis, Pharmaceuticals, 11, 10.3390/ph11010028 Aquino, 2012, Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells, Int. J. Pharm., 426, 100, 10.1016/j.ijpharm.2012.01.026 Varshosaz, 2013, Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery, BioMed Res. Int., 2013, 136859, 10.1155/2013/136859 Hickey, 2013, Dry powder antibiotic aerosol product development: inhaled therapy for tuberculosis, J. Pharm. Sci., 102, 3900, 10.1002/jps.23705 Paranjpe, 2014, Nanoparticle-mediated pulmonary drug delivery: a review, Int. J. Mol. Sci., 15, 5852, 10.3390/ijms15045852 Shiehzadeh, 2016, Dry powder form of polymeric nanoparticles for pulmonary drug delivery, Curr. Pharmaceut. Des., 22, 2549, 10.2174/1381612822666160128150449 Lee, 2015, Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages, Expert Opin. Drug Deliv., 12, 1009, 10.1517/17425247.2015.1039509 Pandey, 2011, Nanomedicine and experimental tuberculosis: facts, flaws, and future, Nanomed. Nanotechnol. Biol. Med., 7, 259, 10.1016/j.nano.2011.01.009 Sosnik, 2010, New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery, Adv. Drug Deliv. Rev., 62, 547, 10.1016/j.addr.2009.11.023 Shen, 2012, Fabrication of inhalable spore like pharmaceutical particles for deep lung deposition, Int. J. Pharm., 430, 98, 10.1016/j.ijpharm.2012.03.044 Yang, 2013, Development of a pulmonary peptide delivery system using porous nanoparticle-aggregate particles for systemic application, Int. J. Pharm., 451, 104, 10.1016/j.ijpharm.2013.04.077 Elzoghby, 2012, Albumin-based nanoparticles as potential controlled release drug delivery systems, J. Control. Release, 157, 168, 10.1016/j.jconrel.2011.07.031 de Boer, 2017, Dry powder inhalation: past, present and future, Expert Opin. Drug Deliv., 14, 499, 10.1080/17425247.2016.1224846 Seo, 2016, Therapeutic advantage of inhaled tacrolimus-bound albumin nanoparticles in a bleomycin-induced pulmonary fibrosis mouse model, Pulm. Pharmacol. Therapeut., 36, 53, 10.1016/j.pupt.2016.01.001 Razavi Rohani, 2014, Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients, Int. J. Pharm., 465, 464, 10.1016/j.ijpharm.2014.02.030 Sinsuebpol, 2013, Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery, Drug Des. Dev. Ther., 7, 861 Verma, 2012, 50 Kubo, 1987, Fluorometric determination of streptomycin in serum by high-performance liquid chromatography using mobile phase containing fluorogenic reagent, Anal. Biochem., 162, 219, 10.1016/0003-2697(87)90030-3 Giovagnoli, 2007, Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery, Int. J. Pharm., 333, 103, 10.1016/j.ijpharm.2006.10.005 Virto, 2007, Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures, Biomaterials, 28, 877, 10.1016/j.biomaterials.2006.09.045 Kunda, 2015, Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation, Pharmaceut. Res., 32, 1341, 10.1007/s11095-014-1538-5 Tafaghodi, 2012, Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: impact of formulation on physicochemical and immunological characteristics, Vaccine, 30, 5341, 10.1016/j.vaccine.2012.06.035 Schlinkert, 2015, The oxidative potential of differently charged silver and gold nanoparticles on three human lung epithelial cell types, J. Nanobiotechnol., 13, 1, 10.1186/s12951-014-0062-4 Chiu, 2014, Effects of human Parvovirus B19 and Bocavirus VP1 unique region on tight junction of human airway epithelial A549 cells, PLoS One, 9, 10.1371/journal.pone.0107970 Parlati, 2009, Pulmonary spray dried powders of tobramycin containing sodium stearate to improve aerosolization efficiency, Pharmaceut. Res., 26, 1084, 10.1007/s11095-009-9825-2 James Fox, 2002 Langer, 2003, Optimization of the preparation process for human serum albumin (HSA) nanoparticles, Int. J. Pharm., 257, 169, 10.1016/S0378-5173(03)00134-0 Elzoghby, 2012, Albumin-based nanoparticles as potential controlled release drug delivery systems, J. Control. Release : official journal of the Controlled Release Society, 157, 168, 10.1016/j.jconrel.2011.07.031 Seo, 2016, Therapeutic advantage of inhaled tacrolimus-bound albumin nanoparticles in a bleomycin-induced pulmonary fibrosis mouse model, Pulm. Pharmacol. Therapeut., 36, 53, 10.1016/j.pupt.2016.01.001 Kim, 2011, Preparation and characterization of Apo2L/TNF-related apoptosis-inducing ligand–loaded human serum albumin nanoparticles with improved stability and tumor distribution, J. Pharm. Sci., 100, 482, 10.1002/jps.22298 Qiang, 2009, Nanoparticle albumin - bound (NAB) technology is a promising method for anti-cancer drug delivery, Recent Pat. Anti-Cancer Drug Discov., 4, 262, 10.2174/157489209789206869 Gustafson, 2015, Nanoparticle uptake: the phagocyte problem, Nano Today, 10, 487, 10.1016/j.nantod.2015.06.006 Buttini, 2018, Dose administration maneuvers and patient care in tobramycin dry powder inhalation therapy, Int. J. Pharm., 548, 182, 10.1016/j.ijpharm.2018.06.006 Pilcer, 2013, New co-spray-dried tobramycin nanoparticles-clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients, J. Pharm. Sci., 102, 1836, 10.1002/jps.23525 Healy, 2014, Dry powders for oral inhalation free of lactose carrier particles, Adv. Drug Deliv. Rev., 75, 32, 10.1016/j.addr.2014.04.005 Nolan, 2009, Excipient-free nanoporous microparticles of budesonide for pulmonary delivery, Eur. J. Pharm. Sci. : official journal of the European Federation for Pharmaceutical Sciences, 37, 593, 10.1016/j.ejps.2009.05.007 Moghaddam, 2013, Development of a nano–micro carrier system for sustained pulmonary delivery of clarithromycin, Powder Technol., 239, 478, 10.1016/j.powtec.2013.02.025 Wilson, 2018, Formulation of high-performance dry powder aerosols for pulmonary protein delivery, Pharmaceut. Res., 35, 195, 10.1007/s11095-018-2452-z Makarević, 2003, Chiral bis(amino alcohol)oxalamide gelators—gelation properties and supramolecular organization: racemate versus pure enantiomer gelation, Chem. Eur J., 9, 5567, 10.1002/chem.200304573 Guthrie, 1979, Introduction to spectroscopy (pavia, Donald; lampman, gary M.; Kriz, george S., Jr.), J. Chem. Educ., 56, A323, 10.1021/ed056pA323.2 Pavia, 2001 Alipour, 2015, Inhalable, large porous PLGA microparticles loaded with paclitaxel: preparation, in vitro and in vivo characterization, J. Microencapsul., 32, 661, 10.3109/02652048.2014.944949 Sivadas, 2008, A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins, Int. J. Pharm., 358, 159, 10.1016/j.ijpharm.2008.03.024 Momin, 2017, Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis, Int. J. Pharm., 528, 107, 10.1016/j.ijpharm.2017.06.004 Rangaraj, 2019, Insight into pulmonary drug delivery: mechanism of drug deposition to device characterization and regulatory requirements, Pulm. Pharmacol. Therapeut., 54, 1, 10.1016/j.pupt.2018.11.004 Forbes, 2015, Dissolution: a critical performance characteristic of inhaled products?; advances and challenges, 384 Parlati, 2009, Pulmonary spray dried powders of tobramycin containing sodium stearate to improve aerosolization efficiency, Pharmaceut. Res., 26, 1084, 10.1007/s11095-009-9825-2 Marier, 2003, Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats, J. Antimicrob. Chemother., 52, 247, 10.1093/jac/dkg317 Griffith, 2018, Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (convert): a prospective, open-label, randomized study, Am J Respir Crit Care Med., 10.1164/rccm.201807-1318OC Donald, 2009, Chapter 59 - antituberculosis drugs, 608 Kumar, 2014, Intranasal delivery of streptomycin sulfate (STRS) loaded solid lipid nanoparticles to brain and blood, Int. J. Pharm., 461, 223 Kurmi, 2010, Micro- and nanocarrier-mediated lung targeting, Expert Opin. Drug Deliv., 7, 781, 10.1517/17425247.2010.492212 Loira-Pastoriza, 2014, Delivery strategies for sustained drug release in the lungs, Adv. Drug Deliv. Rev., 75, 81, 10.1016/j.addr.2014.05.017 Garcia-Contreras, 2007, Inhaled large porous particles of capreomycin for treatment of tuberculosis in a Guinea pig model, Antimicrob. Agents Chemother., 51, 2830, 10.1128/AAC.01164-06 Hwang, 2008, Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis, J. Control. Release : official journal of the Controlled Release Society, 129, 100, 10.1016/j.jconrel.2008.04.009 Shiehzadeh, 2019, Preparation and characterization of a dry powder inhaler composed of PLGA large porous particles encapsulating gentamicin sulfate, Adv. Pharmaceut. Bull., 9, 255, 10.15171/apb.2019.029 Alipour, 2010, Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery, Colloids Surf B Biointerfaces, 10.1016/j.colsurfb.2010.07.050